Acute limb ischemia secondary to vaccine-induced inmune thrombotic thrombocytopenia (VITT) after ChAdOx1 nCoV-19

Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a syndrome that resembles to heparin-induced thrombocytopenia (HIT). Platelet factor 4 (PF-4) reacts to a vaccine component resulting formation of immune complex that stimulates an autoimmune reaction triggering platelet consumption causin...

Full description

Bibliographic Details
Main Authors: Fernando García-Boyano, Clara M. Castro Ávila, Miguel Arguello-Tomás, Álvaro Moreno Cuervo, José Manuel Ligero Ramos, Cristina Pascual-Izquierdo
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Annals of Vascular Surgery - Brief Reports and Innovations
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772687822000642
_version_ 1797788378086768640
author Fernando García-Boyano
Clara M. Castro Ávila
Miguel Arguello-Tomás
Álvaro Moreno Cuervo
José Manuel Ligero Ramos
Cristina Pascual-Izquierdo
author_facet Fernando García-Boyano
Clara M. Castro Ávila
Miguel Arguello-Tomás
Álvaro Moreno Cuervo
José Manuel Ligero Ramos
Cristina Pascual-Izquierdo
author_sort Fernando García-Boyano
collection DOAJ
description Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a syndrome that resembles to heparin-induced thrombocytopenia (HIT). Platelet factor 4 (PF-4) reacts to a vaccine component resulting formation of immune complex that stimulates an autoimmune reaction triggering platelet consumption causing thrombus formation and producing thrombotic events. When suspected is important to confirm for make a correct anticoagulation management to avoid complications related to unfractioned and low weight heparins use.In this report we describe a case of acute limb ischemia secondary to ChAdOx1 nCoV-19 vaccine (Astrazeneca, Cambridge, UK)
first_indexed 2024-03-13T01:34:42Z
format Article
id doaj.art-3a2385cfa2cd4a3c92fcafa5c49761b3
institution Directory Open Access Journal
issn 2772-6878
language English
last_indexed 2024-03-13T01:34:42Z
publishDate 2022-09-01
publisher Elsevier
record_format Article
series Annals of Vascular Surgery - Brief Reports and Innovations
spelling doaj.art-3a2385cfa2cd4a3c92fcafa5c49761b32023-07-04T05:11:50ZengElsevierAnnals of Vascular Surgery - Brief Reports and Innovations2772-68782022-09-0123100102Acute limb ischemia secondary to vaccine-induced inmune thrombotic thrombocytopenia (VITT) after ChAdOx1 nCoV-19Fernando García-Boyano0Clara M. Castro Ávila1Miguel Arguello-Tomás2Álvaro Moreno Cuervo3José Manuel Ligero Ramos4Cristina Pascual-Izquierdo5Angiology and Vascular Surgery Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain; Corresponding author at: Department of Vascular Surgery of Hospital General Universitario Gregorio Marañón de Madrid. Universidad Complutense de Madrid. C/ Dr. Esquerdo 46, Madrid 28007, Spain.Angiology and Vascular Surgery Department, Hospital General Universitario Gregorio Marañon, Madrid, SpainHaematology Department, Hospital General Universitario Gregorio Marañon, Madrid, SpainAngiology and Vascular Surgery Department, Hospital General Universitario Gregorio Marañon, Madrid, SpainAngiology and Vascular Surgery Department, Hospital General Universitario Gregorio Marañon, Madrid, SpainHaematology Department, Hospital General Universitario Gregorio Marañon, Madrid, SpainVaccine-induced immune thrombotic thrombocytopenia (VITT) is a syndrome that resembles to heparin-induced thrombocytopenia (HIT). Platelet factor 4 (PF-4) reacts to a vaccine component resulting formation of immune complex that stimulates an autoimmune reaction triggering platelet consumption causing thrombus formation and producing thrombotic events. When suspected is important to confirm for make a correct anticoagulation management to avoid complications related to unfractioned and low weight heparins use.In this report we describe a case of acute limb ischemia secondary to ChAdOx1 nCoV-19 vaccine (Astrazeneca, Cambridge, UK)http://www.sciencedirect.com/science/article/pii/S2772687822000642VITTAcute limb ischemiaCovid19
spellingShingle Fernando García-Boyano
Clara M. Castro Ávila
Miguel Arguello-Tomás
Álvaro Moreno Cuervo
José Manuel Ligero Ramos
Cristina Pascual-Izquierdo
Acute limb ischemia secondary to vaccine-induced inmune thrombotic thrombocytopenia (VITT) after ChAdOx1 nCoV-19
Annals of Vascular Surgery - Brief Reports and Innovations
VITT
Acute limb ischemia
Covid19
title Acute limb ischemia secondary to vaccine-induced inmune thrombotic thrombocytopenia (VITT) after ChAdOx1 nCoV-19
title_full Acute limb ischemia secondary to vaccine-induced inmune thrombotic thrombocytopenia (VITT) after ChAdOx1 nCoV-19
title_fullStr Acute limb ischemia secondary to vaccine-induced inmune thrombotic thrombocytopenia (VITT) after ChAdOx1 nCoV-19
title_full_unstemmed Acute limb ischemia secondary to vaccine-induced inmune thrombotic thrombocytopenia (VITT) after ChAdOx1 nCoV-19
title_short Acute limb ischemia secondary to vaccine-induced inmune thrombotic thrombocytopenia (VITT) after ChAdOx1 nCoV-19
title_sort acute limb ischemia secondary to vaccine induced inmune thrombotic thrombocytopenia vitt after chadox1 ncov 19
topic VITT
Acute limb ischemia
Covid19
url http://www.sciencedirect.com/science/article/pii/S2772687822000642
work_keys_str_mv AT fernandogarciaboyano acutelimbischemiasecondarytovaccineinducedinmunethromboticthrombocytopeniavittafterchadox1ncov19
AT claramcastroavila acutelimbischemiasecondarytovaccineinducedinmunethromboticthrombocytopeniavittafterchadox1ncov19
AT miguelarguellotomas acutelimbischemiasecondarytovaccineinducedinmunethromboticthrombocytopeniavittafterchadox1ncov19
AT alvaromorenocuervo acutelimbischemiasecondarytovaccineinducedinmunethromboticthrombocytopeniavittafterchadox1ncov19
AT josemanuelligeroramos acutelimbischemiasecondarytovaccineinducedinmunethromboticthrombocytopeniavittafterchadox1ncov19
AT cristinapascualizquierdo acutelimbischemiasecondarytovaccineinducedinmunethromboticthrombocytopeniavittafterchadox1ncov19